[HTML][HTML] Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital …
Y Liu, X Lv, N Xie, Z Fang, W Ren, Y Gong, Y Jin… - BMC cardiovascular …, 2020 - Springer
Background Statin remains a mainstay in the prevention and treatment of cardiovascular
diseases. Statin utilization has evolved over time in many countries, but data on this topic …
diseases. Statin utilization has evolved over time in many countries, but data on this topic …
Prior authorization requirements for proprotein convertase subtilisin/kexin type 9 inhibitors across US private and public payers
JA Doshi, JT Puckett, MS Parmacek… - … Quality and Outcomes, 2018 - Am Heart Assoc
Background: Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9is) are an
innovative treatment option for patients with familial hypercholesterolemia or clinical …
innovative treatment option for patients with familial hypercholesterolemia or clinical …
Initiation patterns of statins in the 2 years after release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) cholesterol management …
T Olufade, S Zhou, D Anzalone, DM Kern… - Journal of the …, 2017 - Am Heart Assoc
Background The purpose of this study was to characterize changes in statin utilization
patterns in patients newly initiated on therapy in the 2 years following the release of the …
patterns in patients newly initiated on therapy in the 2 years following the release of the …
[HTML][HTML] Deintensification or no statin treatment is associated with higher mortality in patients with ischemic stroke or transient ischemic attack
JL Dearborn-Tomazos, X Hu, DM Bravata, MA Phadke… - Stroke, 2021 - journals.lww.com
Background and Purpose: Practice guidelines recommend that most patients receive
moderate-or high-potency statins after ischemic stroke or transient ischemic attack (TIA) of …
moderate-or high-potency statins after ischemic stroke or transient ischemic attack (TIA) of …
Use of lipid lowering drugs in patients at very high risk of cardiovascular events: An analysis on nearly 3,000,000 Italian subjects of the ARNO Observatory
AP Maggioni, S Calabria, E Rossi, N Martini - International Journal of …, 2017 - Elsevier
Aim To assess clinical characteristics, use of resources and costs of patients at very high risk
(VHR) of cardiovascular (CV) events. Further, to assess how VHR patients are treated with …
(VHR) of cardiovascular (CV) events. Further, to assess how VHR patients are treated with …
[HTML][HTML] Clinical characteristics and unmet need among patients with atherosclerotic cardiovascular disease stratified by statin use
Q Huang, M Grabner, RJ Sanchez… - American Health & …, 2016 - ncbi.nlm.nih.gov
Background The American College of Cardiology (ACC)/American Heart Association (AHA)
2013 guidelines for blood cholesterol treatment recommend high-intensity statins for adults …
2013 guidelines for blood cholesterol treatment recommend high-intensity statins for adults …
Trends in high-intensity statin use and low-density lipoprotein cholesterol control among patients enrolled in a clinical pharmacy cardiac risk service
DG Lamprecht Jr, PB Shaw, JB King, KN Hogan… - Journal of Clinical …, 2018 - Elsevier
Background Although high-intensity statin therapy (HIST) is recommended for most patients
between 21 and 75 years of age with atherosclerotic cardiovascular disease (ASCVD) …
between 21 and 75 years of age with atherosclerotic cardiovascular disease (ASCVD) …
[HTML][HTML] A cohort analysis of statin treatment patterns among small-sized primary care practices
Background Small-sized primary care practices, defined as practices with fewer than 10
clinicians, delivered the majority of outpatient visits in the USA. Statin therapy in high-risk …
clinicians, delivered the majority of outpatient visits in the USA. Statin therapy in high-risk …
Utilization and adherence to guideline-recommended lipid-lowering therapy at an academic medical center
KA Alburikan, RM Asiri, AM Alhammad… - Annals of Saudi …, 2017 - annsaudimed.net
BACKGROUND: Clinical guidelines for managing blood cholesterol were updated in
November 2013. OBJECTIVE: To evaluate the adherence to the 2013 American College of …
November 2013. OBJECTIVE: To evaluate the adherence to the 2013 American College of …
Treatment gap in primary prevention patients presenting with acute coronary syndrome
A Bavishi, T Howard, JP Kim, B Hiramoto… - The American Journal of …, 2019 - Elsevier
Previous studies assessing healthcare provider compliance to the 2013 American College
of Cardiology/American Heart Association (ACC/AHA) cholesterol guidelines indicate a …
of Cardiology/American Heart Association (ACC/AHA) cholesterol guidelines indicate a …